The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors
Authors:
Open Access
- 1 January 2023
- journal article
- review article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 19 (4) , 1036-1048
Abstract
Digestive system tumors include malignancies of the stomach, pancreas, colon, rectum, and the esophagus, and are associated with high morbidity and mortality. Aberrant epigenetic modifications play a vital role in the progression of digestive system tumors. The aberrant transcription of key oncogenes is driven by super-enhancers (SEs), which are characterized by large clusters of enhancers with significantly high density of transcription factors, cofactors, and epigenetic modulatory proteins. The SEs consist of critical epigenetic regulatory elements, which modulate the biological characteristics of digestive system tumors including tumor cell identity and differentiation, tumorigenesis, environmental response, immune response, and chemotherapeutic resistance. The core transcription regulatory loop of the digestive system tumors is complex and a high density of transcription regulatory complexes in the SEs and the crosstalk between SEs and the noncoding RNAs. In this review, we summarized the known characteristics and functions of the SEs in the digestive system tumors. Furthermore, we discuss the oncogenic roles and regulatory mechanisms of SEs in the digestive system tumors. We highlight the role of SE-driven genes, enhancer RNAs (eRNAs), lncRNAs, and miRNAs in the digestive system tumor growth and progression. Finally, we discuss clinical significance of the CRISPR-Cas9 gene editing system and inhibitors of SE-related proteins such as BET and CDK7 as potential cancer therapeutics.Keywords
This publication has 138 references indexed in Scilit:
- eRNAs Promote Transcription by Establishing Chromatin Accessibility at Defined Genomic LociMolecular Cell, 2013
- CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and DiseaseISRN Hematology, 2013
- Noncoding Transcription at Enhancers: General Principles and Functional ModelsAnnual Review of Genetics, 2012
- Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase IINature Structural & Molecular Biology, 2012
- BET domain co-regulators in obesity, inflammation and cancerNature Reviews Cancer, 2012
- Epigenetic protein families: a new frontier for drug discoveryNature Reviews Drug Discovery, 2012
- Selective inhibition of BET bromodomainsNature, 2010
- ChIP-seq accurately predicts tissue-specific activity of enhancersNature, 2009
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- High-Resolution Mapping and Characterization of Open Chromatin across the GenomeCell, 2008